Effect of Certain Denture Disinfectants on Surface Topography, Microhardness and Dimensional Stability of CAD/CAM Milled Polymethyl Methacrylate and Polyether Ether Ketone Denture Base Materials
Condition(s) studied
Investigational drug(s) / intervention(s)
M0 group: Immersed in distilled water at 37 c for 6 months
M1 group : PMMA+ Sodium hypochlorite: Immersed in 1% sodium hypochlorite solution for 6 months
M2 group: PMMA+ Chlorhexidine: Immersed in 0.2% chlorhexidine solution for 6 months
M3 group : PMMA + Effervescent Alkaline Peroxide Tablet: Immersed in Effervescent tablet denture cleanser solution for 6 months
E0 group : PEEK control group: Immersed in distilled water at 37 c for 6 months
E1 group : PEEK + Sodium hypochlorite: Immersed in 1% sodium hypochlorite solution for 6 months
E2 group : PEEK +Chlorhexidine group: Immersed in 0.2% chlorhexidine solution for 6 months
E3 group: PEEK + Effervescent Alkaline Peroxide Tablet: Immersed in Effervescent tablet denture cleanser solution for 6 months
Study summary
This study aims to evaluate and compare the influence of different denture cleansing methods using 1% sodium hypochlorite solution, 0.2% chlorhexidine solution and effervescent alkaline peroxide tablet solution -according to manufacturer's instructions- on surface roughness , microhardness and dimensional stability (%) of CAD-CAM Milled both Polymethyl methacrylate and Polyether Ether Ketone denture base materials.
Eligibility
Primary outcome measure(s)
- Surface Roughness Measurement — 6 months
Surface roughness (Ra) was measured using a profilometer. Each specimen was scanned at three random locations, and the mean value was recorded. The device was calibrated using the manufacturer's reference standard prior to each measurement session.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Menoufia University | Shibīn al Kawm | Egypt |
More Menoufia University trials in Egypt
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07672847 on ClinicalTrials.gov ↗ ← All trials in Egypt